Cambridge, Massachusetts 02139, United States
Geoff Mackay, George Church, Luhan Yang, Kenneth Fan, Paul Sekhri, William Westlin, Michael Curtis, Elizabeth Roberts
2014
50
Private company
Series C
265.0
ARCH Venture Partners, Khosla Ventures, Polaris Partners, Alta Partners, Invus, Catalio Capital Managment, Wellington Partners, etc.
Cell Loss
kidney failure, Type 2 diabetes
tissue engineering, organ engineering, xenotransplantation
Uniquely positioned to reinvigorate the field of xenotransplantation.
eGenesis is a gene editing and genome engineering company committed to the development of safe and effective human transplantable organs, tissues and cells to address the global organ crisis.